Stuart W. Young
YOU?
Author Swipe
View article: Design of the Del-1 for Therapeutic Angiogenesis Trial (DELTA-1), a Phase II Multicenter, Double-Blind, Placebo-Controlled Trial of VLTS-589 in Subjects with Intermittent Claudication Secondary to Peripheral Arterial Disease
Design of the Del-1 for Therapeutic Angiogenesis Trial (DELTA-1), a Phase II Multicenter, Double-Blind, Placebo-Controlled Trial of VLTS-589 in Subjects with Intermittent Claudication Secondary to Peripheral Arterial Disease Open
The objective of this phase II investigation is to assess the safety and efficacy of a plasmid mediated approach to induce angiogenesis/arteriogenesis with the angiomatrix protein Del-1 (developmentally regulated endothelial locus 1), in s…
View article: 194. Deltavasc™ - Phase I Study of Intramuscular Administration of Plasmid Del-1 (Developmentally Regulated Endothelial Cell Locus –1) in Humans with Peripheral Arterial Disease (PAD)
194. Deltavasc™ - Phase I Study of Intramuscular Administration of Plasmid Del-1 (Developmentally Regulated Endothelial Cell Locus –1) in Humans with Peripheral Arterial Disease (PAD) Open
Background: Del-1 (Developmentally regulated endothelial locus 1) is a novel angiomatrix protein that induces a potent angiogenic response. Preclinical studies using a plasmid expressing Del-1 in conjunction with a poloxamer (VLTS-589) hav…
View article: Safety and Efficacy of Mangafodipir Trisodium (MnDPDP) Injection for Hepatic MRI in Adults: Results of the U.S. Multicenter Phase III Clinical Trials (Safety)
Safety and Efficacy of Mangafodipir Trisodium (MnDPDP) Injection for Hepatic MRI in Adults: Results of the U.S. Multicenter Phase III Clinical Trials (Safety) Open
The short-term safety of mangafodipir trisodium (MnDPDP) injection was studied in 546 adults with known or suspected focal liver lesions. An initial contrast-enhanced computed tomography examination was followed by unenhanced magnetic reso…
View article: Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: Results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging
Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: Results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging Open
The efficacy of contrast-enhanced magnetic resonance imaging (MRI) for detecting and characterizing, or excluding, hepatic masses was assessed in 404 patients, following the intravenous administration of mangafodipir trisodium (MnDPDP) inj…
View article: Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI.
Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI. Open
Gadolinium(III) texaphyrin (Gd-tex2+) is representative of a new class of radiation sensitizers detectable by magnetic resonance imaging (MRI). This porphyrin-like complex has a high electron affinity [E1/2 (red.) approximately = -0.08 V v…
View article: Note on the Standardization of Iodine Solutions.
Note on the Standardization of Iodine Solutions. Open
n/a
View article: ON THE INHIBITION OF CHEMICAL REACTIONS BY FOREIGN SUBSTANCES. I.
ON THE INHIBITION OF CHEMICAL REACTIONS BY FOREIGN SUBSTANCES. I. Open
n/a
View article: ON IODOSTANNOUS ACID.
ON IODOSTANNOUS ACID. Open
n/a
View article: THE VOLUMETRIC DETERMINATION OF THE NITRO GROUP IN ORGANIC COMPOUNDS.
THE VOLUMETRIC DETERMINATION OF THE NITRO GROUP IN ORGANIC COMPOUNDS. Open
n/a